JAGSONPAL PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Jagsonpal Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.14₹ -0.25
As on Jan 16, 2026, 12:05 PM IST
Jagsonpal Pharmaceuticals Price Performance
Today's LowToday's High
₹175.35₹178.90
₹178.90
52 Weeks' Low52 Weeks' High
₹176.05₹301.80
₹178.90
Open Price
₹177.65
Prev. Close
₹179.15
Volume
849
Over the last 5 years, the share price of Jagsonpal Pharmaceuticals has gained 41.09% CAGR. Over the past year, the corresponding return has been -14.83%.
Jagsonpal Pharmaceuticals’s current P/E of 19.32x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Jagsonpal Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals | -4.13 | -10.42 | -19.94 | -27.34 | -14.83 | 6.65 | 41.09 |
| Sun Pharmaceutical Industries | -4.8 | -6.69 | 1.38 | -2.94 | -4.55 | 17.44 | 22.66 |
| Divi's Laboratories | -4.2 | -0.44 | -3.85 | -6.92 | 7.51 | 23.77 | 11.65 |
| Torrent Pharmaceuticals | -0.65 | 5.76 | 13.21 | 16.26 | 24.41 | 36.61 | 24.15 |
| Cipla | -4.01 | -6.98 | -10.01 | -5.96 | -3.1 | 9.77 | 11.23 |
| Lupin | 0.62 | 5.45 | 13.57 | 12.95 | 3.56 | 42.81 | 15.06 |
| Dr. Reddy's Laboratories | -1.52 | -7.13 | -3.52 | -5.71 | -11.2 | 11.18 | 2.69 |
| Mankind Pharma | -3.31 | 1.83 | -10.78 | -17.73 | -15.93 | 15.23 | 8.88 |
| Zydus Lifesciences | -2.82 | -4.26 | -9.75 | -8.8 | -10.44 | 26.17 | 12.56 |
| Alkem Laboratories | 0.82 | 4.05 | 4.86 | 18.45 | 12.36 | 24.33 | 13.48 |
| Aurobindo Pharma | -1.85 | -0.09 | 6.78 | 2.81 | 3.23 | 38.46 | 4.81 |
| Abbott India | -0.9 | 0.65 | -5.71 | -18.2 | 1.13 | 8.4 | 13.36 |
| Laurus Labs | -1.65 | 7.81 | 23.66 | 30.9 | 94.42 | 45.15 | 23.99 |
| Biocon | 1.6 | -1.68 | 7.82 | -1.59 | 0.42 | 15.3 | -3.41 |
| Glenmark Pharmaceuticals | -3.17 | 1.36 | 6.3 | -9.63 | 36.25 | 68.56 | 31.46 |
| GlaxoSmithKline Pharmaceuticals | -1.83 | -8.55 | -13.94 | -26.4 | 15.25 | 21.83 | 9.21 |
| Ipca Laboratories | -2.2 | 4.69 | 15.93 | 2.64 | -3.61 | 20.26 | 7.41 |
| Anthem Biosciences | -3.51 | -10.98 | -19.79 | -14.81 | -14.81 | -5.2 | -3.16 |
| Ajanta Pharma | -5.53 | 1.48 | 11.17 | -0.83 | -7 | 31.59 | 18.12 |
| J B Chemicals & Pharmaceuticals | -0.4 | 6.13 | 14.16 | 15.17 | 7.77 | 25.08 | 29.56 |
Over the last one year, Jagsonpal Pharmaceuticals has declined 14.83% compared to peers like Sun Pharmaceutical Industries (-4.55%), Divi's Laboratories (7.51%), Torrent Pharmaceuticals (24.41%). From a 5 year perspective, Jagsonpal Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (22.66%) and Divi's Laboratories (11.65%).
Jagsonpal Pharmaceuticals Financials
Jagsonpal Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 182.12 | 182.29 |
| 10 | 186.58 | 185.78 |
| 20 | 192.41 | 190.9 |
| 50 | 202.02 | 201.05 |
| 100 | 215.99 | 211.38 |
| 200 | 225.13 | 216.82 |
Jagsonpal Pharmaceuticals Share Holding Pattern
In the latest quarter, Jagsonpal Pharmaceuticals saw a drop in promoter holding to 67.54%, while DII stake increased to 0.08%, FII holding fell to 2.12%, and public shareholding moved up to 30.25% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Jagsonpal Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 15, 2026, 10:17 PM IST | Jagsonpal Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Jan 13, 2026, 9:56 PM IST | Jagsonpal Pharma - Board Meeting Intimation for Intimation Of Board Meeting |
| Jan 06, 2026, 10:44 PM IST | Jagsonpal Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 06, 2026, 10:32 PM IST | Jagsonpal Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Dec 30, 2025, 10:21 PM IST | Jagsonpal Pharma - Announcement Under Regulation 30 Of SEBI (LODR), 2015 |
About Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 268.72 Cr. and Equity Capital is Rs. 13.28 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressInnov8 3rd Floor, New Delhi Delhi 110020
- Contact
Management
- Mr. Rajpal Singh KochharChairman Emeritus
- Mr. Harsha RaghavanChairman & Non-Exe.Director
- Mr. Manish GuptaManaging Director
- Mr. Prithipal Singh KochharNon Executive Director
- Mr. Debasis Bikash NandyIndependent Director
- Ms. Radhika Madhukar DudhatIndependent Director
- Ms. Pallavi Dinodia GuptaIndependent Director
FAQs on Jagsonpal Pharmaceuticals Share Price
What is the share price of Jagsonpal Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Jagsonpal Pharmaceuticals is ₹178.90 as on Jan 16, 2026.
What kind of stock is Jagsonpal Pharmaceuticals?
The Jagsonpal Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Jagsonpal Pharmaceuticals?
The market cap of Jagsonpal Pharmaceuticals is ₹1,196.67 Cr as on Jan 16, 2026.
What are today's High and Low prices of Jagsonpal Pharmaceuticals?
Today’s highest and lowest price of Jagsonpal Pharmaceuticals are ₹178.90 and ₹175.35.
What are the 52 Week High and 52 Week Low of Jagsonpal Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Jagsonpal Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Jagsonpal Pharmaceuticals is ₹301.80 and 52-week low of Jagsonpal Pharmaceuticals is ₹176.05 as on Jan 16, 2026.
How has the Jagsonpal Pharmaceuticals performed historically in terms of returns?
The Jagsonpal Pharmaceuticals has shown returns of -0.14% over the past day, -10.42% for the past month, -19.94% over 3 months, -14.83% over 1 year, 6.65% across 3 years, and 41.09% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Jagsonpal Pharmaceuticals?
P/E ratio of and PB ratio of Jagsonpal Pharmaceuticals are 19.32 and 4.73 on Jan 16, 2026. While the company gives a dividend yield of 1.40 per annum.
✕
Market Pulse